Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 141.61
0.79 %
$ 20.7 B
Market Cap
12.67
P/E
BIIB - OPERATING INCOME
Operating Income BIIB - Biogen Inc.
5.23 B
LAST VALUE
50.14%
2 YEAR CAGR
-5.78%
5 YEAR CAGR
2.79%
10 YEAR CAGR